Tomas Kahn
Corporate Officer/Principal en LSCN Ltd. .
Origen de la red de primer grado Tomas Kahn.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Private Company | Pharmaceuticals: Major | 5 | |
German Cancer Research Center
German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany.
3
| Private Company | Hospital/Nursing Management | 3 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Tomas Kahn a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Chairman | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
PAION AG | Pharmaceuticals: Major | Director/Board Member | |
ProBioGen AG
ProBioGen AG Miscellaneous Commercial ServicesCommercial Services ProBioGen AG operates as a contract development and manufacturing organization. It specializes in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. The firm offers services such as cell line development, process development, manufacturing programs, physio-chemical analyses, and cell-based assays. The company was founded by Uwe Marx on June 13, 1994 and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
PCI BIOTECH HOLDING ASA | Biotechnology | Corporate Officer/Principal | |
Generali Deutschland Versicherung AG
Generali Deutschland Versicherung AG Insurance Brokers/ServicesFinance Part of Assicurazioni Generali SpA, Generali Deutschland Versicherung AG provides insurance brokerage services. The company is based in Aachen, Germany. The German company was founded in 1825 by David Hansemann. Christoph Schmallenbach has been the CEO of the company since 2015. | Insurance Brokers/Services | Chief Executive Officer | |
EVOTEC SE | Pharmaceuticals: Major | Chairman | |
RECORDATI | Pharmaceuticals: Major | Director/Board Member | |
PHOTOCURE ASA | Medical Specialties | Corporate Officer/Principal | |
Arrow Therapeutics Ltd.
Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
Universität zu Köln | College/University | Doctorate Degree | |
Technische Universität Darmstadt | College/University | Undergraduate Degree | |
HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director of Finance/CFO | |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chairman | |
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
Epidauros Biotechnologie AG
Epidauros Biotechnologie AG Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., Epidauros Biotechnologie AG is a German company that specializes in pharmacogenomics research. The company is based in Bernried, Germany. Epidauros Biotechnologie was acquired by Clinical Data BV from Deutsche Effecten & Wechsel Beteiligungs AG on August 23, 2007 for $11.83 million. | Miscellaneous Commercial Services | Chairman | |
Apogenix AG
Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Director/Board Member | |
NYKODE THERAPEUTICS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BIO Deutschland
BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
German Institute of Human Nutrition | Director/Board Member | ||
Oldenburg University Of | College/University | Doctorate Degree | |
Pflüger Schulz Rogalla Unternehmensberatung GmbH | Corporate Officer/Principal | ||
INSTRUCT AG | Director/Board Member | ||
Amerigo AG | Corporate Officer/Principal | ||
anwerina AG
anwerina AG Miscellaneous Commercial ServicesCommercial Services Anwerina AG is a pharmaceutical company based in Germany that specializes in the development of quality drugs and medical technology for the treatment of bone diseases. The Swiss company is experts in the field of osteoporosis and have a patient-centered strategy for the development of unique and cost-effective drugs. The private company offers ASCENDRA® / ASCENDRA® DUO / ASCENDRA® TRIO, which is an injection solution used for the therapy of osteoporosis in postmenopausal women with an increased risk of fractures. The company also focuses on the development of generic drugs for patients with bone metastases in the field of oncology. | Miscellaneous Commercial Services | Director/Board Member | |
Technische Hochschule Nürnberg Georg Simon Ohm | College/University | Corporate Officer/Principal | |
TME PHARMA N.V. | Biotechnology | Director/Board Member | |
Acxit Lifesciences GmbH
Acxit Lifesciences GmbH Investment ManagersFinance Acxit Lifesciences GmbH provides financial and strategic advisory services. The private company is based in Frankfurt, Germany. Richard F. Chambers has been the CEO of the German company since 2004. | Investment Managers | Chief Executive Officer |
Estadísticas
Internacional
Alemania | 25 |
Noruega | 5 |
Estados Unidos | 4 |
Dinamarca | 3 |
Italia | 2 |
Sectorial
Health Technology | 17 |
Commercial Services | 7 |
Consumer Services | 7 |
Finance | 4 |
Health Services | 2 |
Operativa
Director/Board Member | 20 |
Corporate Officer/Principal | 11 |
Chairman | 7 |
Doctorate Degree | 4 |
Director of Finance/CFO | 3 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Tomas Kahn
- Conexiones Empresas